ACEPODIA ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR ACE723, A NOVEL DUAL-PAYLOAD ANTIBODY-DRUG CONJUGATE

Reuters · 2d ago

Please log in to view news